Open notebook · Approval & compounding

Approval is a wordworth checking.

Learn which product is being discussed. Next, ask for the reason behind offering that product for your goal.

Word to keep

Approval is for a named medicine and use.

Which product? Which use?

FDA approval tells you that the Food and Drug Administration has reviewed that medicine for a stated use.

Ask for the exact drug name and the use on its label. Then ask how the labelled use compares with the purpose proposed for your care.

Made to order is a different term.

Compounded

A pharmacist or doctor prepares a compounded medicine rather than supplying a drug company’s ready-made version.

The FDA says a custom medicine may help with a medical need an approved product cannot address. This guidance was checked in September 2026.

Ask what change is needed for your care.

Approval status

Compounded drugs have not been approved by the FDA. Before sale, the agency does not review how well they were made, how well they work or their safety. This was checked on 26 September 2026.

Ask who prepares the medicine and how to check that source.

The reason for a custom medicine and its approval status are separate questions.

A familiar name can leave a gap.

BPC-157 is not an approved US product

No US medicine containing BPC-157 had FDA approval in the records checked on 26 September 2026.

For a goal such as returning to training, ask what evidence supports the proposed plan and what other treatment paths fit the problem.

What about a custom copy?

The patient’s need matters

Pharmacies could not regularly make almost identical copies of a ready-made medicine that was already available. This rule was checked in September 2026.

When a pharmacy prepares medicine for an individual patient, the rule permits a change that makes an important difference for that patient. The person ordering the medicine must decide that the difference matters.

One possible reason to use a custom medicine is an allergy to a ready-made product’s dye.

A lower price does not count as the important difference required by this rule.

Semaglutide and tirzepatide are medicines used for weight or blood-sugar problems.

Neither semaglutide injections nor tirzepatide injections appeared on the FDA’s national shortage list when checked on 26 September 2026.

Ask: what is the reason for this custom product in my case?

Carry this into the visit.

What is the exact medicine, what is the goal, and why this version? A clear answer gives you something concrete to compare.

Next word: telehealth